Body

Study finds that yo-yo dieting does not thwart weight loss efforts or alter metabolism long term

SEATTLE – Yo-yo dieting – the repetitive loss and regain of body weight, also called weight cycling – is prevalent in the Western world, affecting an estimated 10 percent to 40 percent of the population. The degree to which weight cycling may impact metabolism or thwart a person's ability to lose weight in the long run has been unclear – until now.

Denosumab superior to zoledronic acid for breast cancer patients with bone metastases

Treatment with denosumab resulted in a greater reduction in skeletal-related events in patients with breast cancer that spread to the bones compared with zoledronic acid, while also maintaining health-related quality of life, according to the results of a phase III study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Plants exhibit a wide range of mechanical properties, engineers find

-- From an engineer's perspective, plants such as palm trees, bamboo, maples and even potatoes are examples of precise engineering on a microscopic scale. Like wooden beams reinforcing a house, cell walls make up the structural supports of all plants. Depending on how the cell walls are arranged, and what they are made of, a plant can be as flimsy as a reed, or as sturdy as an oak.

A recipe for increased colorectal cancer screening rates

Screening colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability to screen large numbers of individuals is especially important for states with tight health insurance budgets dealing with aging populations. However, in 2010 only 65 percent of US adults between ages 50 and 75 got the recommended screening. A University of Colorado Cancer Center study recently published in the American Journal of Managed Care demonstrates a systematic approach to improve screening rates.

New technology revising how evolution has shaped modern Europeans

A report in Trends in Genetics says that new analytical techniques are changing long-held, simplistic views about the evolutionary history of humans in Europe. Their findings indicate that many cultural, climatic, and demographic events have shaped genetic variation among modern-day European populations and that the variety of those mechanisms is more diverse than previously thought.

Finding new research frontiers in a single cell

In Lee's study of cottonseeds, done in partnership with a team of U.S. and German scientists, the technique showed a distribution of lipids that varies with tissue function. The knowledge could yield useful information about cottonseed, a crop valued as a possible source of biofuel and for its oil in the food industry.

TREX proteins could see new treatments for cancer realized

Proteins could hold the key to future treatments for a wide range of chronic health problems including Motor Neuron Disease, myotonic dystrophy and a wide range of cancers, University of Sheffield scientists have revealed.

Experts from the University's Department of Molecular Biology and Biotechnology, collaborating with scientists from Harvard Medical School in the USA, have revealed how a complicated set of proteins called TREX act as a passport for the transfer of cell blueprints which create proteins that are essential for life.

Scientists devise new strategy to destroy multiple myeloma

Virginia Commonwealth University Massey Cancer Center are reporting promising results from laboratory and animal experiments involving a new combination therapy for multiple myeloma, the second most common form of blood cancer.

Why some engineered tissue transplants work better than others

Tissue implants made of cells grown on a sponge-like scaffold have been shown in clinical trials to help heal arteries scarred by atherosclerosis and other vascular diseases. However, it has been unclear why some implants work better than others.

Launching a 'social networking war' against cancer

that, more than ever before, modern wars will be fought in the cyber zone, targeting an enemy's communications technology to cause untold damage. Now a Tel Aviv University researcher is suggesting that the same tactics should be employed in the battle against one of the body's deadliest enemies — cancer.

Inclusion body disease: Mysterious snake malady decoded

A novel virus has been identified as the possible cause of a common but mysterious disease that kills a significant number of pet snakes all over the world, thanks to research led by scientists at the University of California, San Francisco (UCSF)—and three snakes named Juliet, Balthazar and Larry.

Alcohol consumption linked to more lung cancer (yet high BMI leads to less)

There may be some truth to the idea that smokers and drinkers eat less and stay thin.

Heavy alcohol consumption was linked to a greater risk of developing lung cancer, while higher BMI and increased consumption of black tea and fruit are associated with lower risk of the deadly disease, according to studies presented last year at the annual meeting of the American College of Chest Physicians (ACCP).

The scent of love? Decomposition and male sex pheromones

Female hide beetles (Dermestes maculatus) are attracted to cadavers by a combination of cadaver odour and male sex pheromones, finds a new study in BioMed Frontiers in Zoology. Neither cadaver scent, nor male sex pheromones alone, caught the fancy of the fussy females. This predilection ensures that there is both a waiting male and food for her larvae, and optimises the chances of reproductive success.

Modification of tumor suppressor affects sensitivity to potential glioblastoma treatment

Despite years of research, glioblastoma, the most common and deadly brain cancer in adults, continues to outsmart treatments targeted to inhibit tumor growth.

Biologists and oncologists have long understood that a protein called the epidermal growth factor receptor or EGFR is altered in at least 50 percent of patients with glioblastoma. Yet patients with glioblastoma either have upfront resistance or quickly develop resistance to inhibitors aimed at stopping the protein's function, suggesting that there is another signalling pathway at play.

Blood test could guide treatment for kidney cancer

DURHAM, N.C. – A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer Institute.

The finding, published online Monday, Aug. 13, 2012, in the Journal of Clinical Oncology, could lead to the first blood test to determine the best treatment for late-stage kidney cancer.